1例社区获得性铜绿假单胞菌肺脓肿患者的抗感染用药分析  

Analysis of Antibiotics Use in One Case of Community-acquired Pseudomonas aeruginosa Lung Abscess

作　　者：张觅[1] 王丽慧[2] 张颖佩[1] 鄢欢[1] 吴东方[1] 刘巍[1] 程虹[1] 

机构地区：[1]武汉大学中南医院药学部,武汉430071 [2]武汉大学中南医院呼吸内科,武汉430071

出　　处：《中国药房》2015年第35期5024-5026,共3页China Pharmacy

摘　　要：目的:探讨临床药师在社区获得性铜绿假单胞菌肺脓肿患者药物治疗中的作用。方法:临床药师参与1例社区获得性铜绿假单胞菌肺脓肿患者的治疗,对患者抗感染用药方案进行分析,及时调整用药来纠正抗感染药物致粒细胞缺乏。结果:医师采纳临床药师建议,成功控制感染并纠正粒细胞缺乏。结论:社区获得性铜绿假单胞菌肺脓肿发病率极低,但病死率高,临床药师介入患者的药物治疗,协助医师完善和优化治疗方案,使患者治疗方案个体化,提高了患者的治愈率。OBJECTIVE：To explore the role of clinical pharmacist in the therapy for patient with community-acquired Pseudomonas aeruginosa lung abscess. METHODS：Clinical pharmacist participated in the therapy for a patient with community-acquired P. aeruginosa lung abscess,analyzed anti-infective therapy plan,and adjusted drug use timely to correct agranulocytosis induced by anti-infective drugs. RESULTS：The physicians adopted the suggestions of clinical pharmacists,controlled the infection successfully and corrected agranulocytosis. CONCLUSIONS：Community-acquired P. aeruginosa lung abscess is rare but has high mortality.Clinical pharmacists participate in drug therapy,assist physician to improve and optimize therapy plan and formulate individual medication plan so as to promote promote care rate of patients.

关 键 词：社区获得性铜绿假单胞菌肺脓肿 抗感染用药 粒细胞缺乏 药学服务 

分 类 号：R96[医药卫生—药理学]